Ignite Creation Date:
2025-12-24 @ 5:01 PM
Ignite Modification Date:
2026-01-24 @ 11:03 PM
Study NCT ID:
NCT06431750
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-01-14
First Post:
2024-04-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-08-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-30
First Submit QC Date:
None
Study First Post Date:
2024-05-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-12
Last Update Post Date:
2025-01-14
Last Update Post Date Type:
ACTUAL